2Meittinen M, Lasola J. Gastrointestinal stromal tumors-definition,clinical, histological, immunohistochemical, and differential diagnosis. Virchows Arch, 2001, 438: 1-12.
3Bucldey JA, Fishman EK. CT evaluation of small bowel neoplasms: spectrum of disease. Radiographies, 1998, 18: 379-392.
4Palazzo L, Landi B, Cellier C, et al. Endosonographic features predictive of benign and malignant gastrointestinal stroma cell tumors. Gut, 2000, 46: 88-92.
5Chhieng DC, Jhala D, Jhala N, et al. Endoscopic ultrasound-guided fine-needle aspiration biopsy: a study of 103 cases. Cancer,2002, 96: 232-239.
6Franqument DW, Frierson HF. Muscle differentiation and clinicopathologic features of gastrointestinal stromal cell tumors.Am J Surg Pathol, 1992, 16: 947.
7Ng EH, Pollock RE, Munsell MF, et al. Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Ann Surg, 1992, 215: 68-77.
8Crosby JA, Catton LN, Davis A, et al. Malignant gastrointestinal stromal tumors of the small imtestine: a review of 50 cases from a prospective database. Ann Surg Oncol, 2001, 8: 50-59.
9DeMatteo R, Lewis JJ, Leung D, et al. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg, 2000, 231: 51-58.
10Joensun H, Roberts PT, Sarlomo RM, et al. Effect of the tyrosine kinase inhibitor STI 571 in a patient with a metaslatic gastrointestinal stromal tumor. N Engl J Med, 2001, 344: 1052-1056.
